Sentences with phrase «virus vaccine research»
The working group's recent recommendation to include pregnant women in the Zika virus vaccine research agenda has already reached a global audience.
https://gumc.georgetown.edu/ Not exact matches
The Albert and Mary Lasker Foundation announced yesterday that it was presenting its prestigious 2017 Lasker - DeBakey Clinical Medical Research Award to a pair of National Cancer Institute researchers, Douglas Lowy and John Schiller, who created a vaccine to prevent human papilloma virus, or HPV, from taking hold in the body.
National and local health care officials said cuts in federal spending to combat the Zika virus means fewer pregnant women will be tested and there will be less money available to develop a vaccine and research how the disease affects fetal brains.
«HIV - 1 viruses transmitted at birth are resistant to antibodies in mother's blood: New research supports creation of vaccine to boost mother's immune response to HIV - 1 before delivery.»
The long - term persistence of CD8αα + T cells where initial infection occurs may explain why patients have asymptomatic recurrences of genital herpes because these cells constantly recognize and eliminate the virus, according to Jia Zhu, Ph.D., corresponding author, research assistant professor in Laboratory Medicine at the University of Washington and an affiliate investigator in the Fred Hutch Vaccine and Infectious Disease Division.
Ebola is one of a number of viruses, including HIV and dengue, that have not surrendered to vaccines after decades of intensive research.
«We could visualize this complex dance between the virus and the antibody and understand exactly how the virus was teaching the antibody to be a broadly neutralizing antibody,» said Peter D. Kwong, Ph.D., chief of the Structural Biology Section at the NIAID Vaccine Research Center.
Contributing to work on smallpox, polio, and vaccine development, primates allow research on potential treatments for hepatitis C and B, Ebola and Marburg viruses, and HIV / AIDS.
For their research, Pekosz and his team, using human nasal tract cells, studied the weakened strain of the flu virus that is used in the nasal spray vaccine and compared its behavior with that of the flu virus itself.
The findings build on earlier research suggesting that the high - dose vaccine may be better at preventing influenza virus infections and other flu - related outcomes in seniors, including office visits and hospitalizations, compared to the standard - dose vaccine.
Healthy adults mounted strong immune responses after receiving an investigational whole inactivated Zika virus vaccine, according to interim analyses of three Phase 1, placebo - controlled, double - blind trials conducted at Beth Israel Deaconess Medical Center (BIDMC), Walter Reed Army Institute of Research (WRAIR), and Saint Louis University School of Medicine.
«When viruses are unavailable for work in the lab, that is really a downside,» says Larry Smith, vice president of vaccine research at Vical Inc. in San Diego.
Despite years of trying, scientists still haven't created an HIV vaccine that can protect people against the virus, says Alan Aderem, a biologist at the Center for Infectious Disease Research in Seattle.
The group created «heartier influenza viruses» to «streamline vaccine production,» which places the research in the GOF category, suggesting that its valuable contribution to vaccine development efforts might not have been allowed under current policies.
The first live - attenuated Zika vaccine still in the development stage completely protected mice against the virus after a single vaccination dose, according to new research from The University of Texas Medical Branch at Galveston and Instituto Evandro Chagas at the Ministry of Health in Brazil.
These are «not the typical virus - fighting cells,» says co-author Gregory Poland, head of the Mayo Clinic's vaccine research group in Rochester, Minnesota.
A chimpanzee virus could provide a useful alternative for vaccine development, according to new research in mice.
«This research team's dedication and previous research on dengue and other arboviruses enabled them to quickly develop this model for Zika virus, an important first step to enable testing of candidate vaccine and therapeutics,» said Stephen Higgs, PhD, the president of the American Society of Tropical Medicine and Hygiene.
Sun is currently conducting collaborative research with hydrogels for applications and efficiency with anticancer drugs screening and delivery, stem cells and wound healing, as well as being used in vaccines for H1N1 influenza and animal diseases, such as the porcine reproductive and respiratory syndrome virus, or PRRS.
By defining the threshold of the amount of virus needed for transmission, the research also provides a target that experimental dengue vaccines and drugs must prevent the virus from reaching in order to be successful at preventing the spread of disease during natural infection.
Because this research does not require replicating «live» viruses, it does not need to be done in high - level containment facilities when developing vaccines for highly pathogenic viruses.
Kang's primary research focuses on designing and developing effective vaccines against viral diseases such as influenza virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to study if ginseng can be used to improve health and protect against disease because of the potential benefit in fighting these viruses.
Despite the accelerated pace of research, much remains unknown about the virus, raising unique challenges in developing a vaccine.
The research and public - health networks established during the SARS epidemic — and the body of coronavirus research that followed — puts scientists today in a much stronger position to understand the latest virus and to develop countermeasures such as drugs and vaccines, should they be required.
Kirschstein worked on another aspect of vaccine safety, doing «very prominent» early research on another virus, simian virus 40, which contaminated some of the monkey cells used to grow poliovirus for the Salk vaccine, says Singer, who later joined the same field.
In a previously published paper, Barouch and colleagues, including Colonel Nelson L. Michael, MD, PhD, director of the Military HIV Research Program at the Walter Reed Army Institute of Research (WRAIR) and Stephen Thomas, MD, Upstate Medical University, State University of New York, demonstrated that three different vaccine candidates provided robust protection against Zika virus in both mice and rhesus monkeys.
«Seasonal flu vaccines boost immunity to many types of flu viruses, research suggests.»
A lab at the center of a longstanding controversy about dangerous virus research has engineered heartier influenza viruses that could streamline vaccine production.
But since a substantial part of the harmful effects of Zika virus infection may occur in the early part of pregnancy, administering vaccines prior to pregnancy or early in pregnancy may be most beneficial, and more clinical research is needed for this time period.
A novel vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, protected cattle from respiratory syncytial virus (RSV) infection, according to research published online in npj Vaccines on March 8.
The vaccine has particular significance because the regions where outbreaks of the two viruses occur overlap, says Donald Black, head of the capripox virus group at the Agricultural and Food Research Council's Institute for Animal Health.
A research team that includes scientists with Kansas State University's Biosecurity Research Institute has developed a promising Zika virus research team that includes scientists with Kansas State University's Biosecurity Research Institute has developed a promising Zika virus Research Institute has developed a promising Zika virus vaccine.
This new discovery, funded by multiple groups, opens up novel possibilities for future research aimed at developing vaccines against these viruses to prevent type 1 diabetes.
A study led by St. Jude Children's Research Hospital identifies new path to a universal influenza vaccine emphasizing production of broadly specific antibodies that target multiple flu viruses
Since there is no vaccine or specific approved treatment for Ebola virus disease (EVD), there is a «moral obligation» to collect and share all data generated, to understand the safety and efficacy of any intervention, and to evaluate promising interventions to inform future research, says Dr. Eleanor Fish, the senior author and senior scientist in the Toronto General Hospital Research Institute research, says Dr. Eleanor Fish, the senior author and senior scientist in the Toronto General Hospital Research Institute Research Institute (TGHRI).
«This vaccine is a successful advancement in developing control strategies for Zika virus by creating widespread immunity in susceptible populations,» said Stephen Higgs, director of the Biosecurity Research Institute.
This paper showcased research results from the new DNA - based Zika vaccine that is based on synthetic DNA and gives instructions to the body's immune system to produce antibodies to attack Zika antigens (i.e. bacteria, viruses, and other foreign substances that trigger immune responses from the body.)
Research interests include Infection and Immunological Conditions; Vaccines and vaccinology; Virus diseases; Virology.
The clinical research center CAIMED, part of Ponce Health Sciences University in Puerto Rico, will examine the vaccine's safety and immunogenicity in participants who have already been naturally exposed to Zika or dengue viruses
Previous vaccine research has failed when the body, even when given an immunity booster, couldn't keep up with the ever - changing virus.
The Walter Reed Army Institute of Research (WRAIR) began vaccinations today in a Phase 1 human clinical trial to test the safety and immunogenicity of the Zika purified inactivated virus (ZPIV) vaccine.
Dr. Pontiano Kaleebu, Chairman Africa AIDS Vaccine Program and Acting Director of Uganda Virus Research Institute, delivered a strong keynote address that reiterated the importance of an HIV vaccine, what it will take to develop an effective vaccine and how community members can help with the international Vaccine Program and Acting Director of Uganda Virus Research Institute, delivered a strong keynote address that reiterated the importance of an HIV vaccine, what it will take to develop an effective vaccine and how community members can help with the international vaccine, what it will take to develop an effective vaccine and how community members can help with the international vaccine and how community members can help with the international effort.
Ernestine Mefor Halle University of Yaounde II / Cameroon Virus Research Institute / International AIDS Vaccine Initiative / HIV Vaccine Program,, Cameroon
Scientists could be one step closer to developing long - awaited vaccines against viruses such as Zika, West Nile or HIV, thanks to research at Penn State College of Medicine.
His ongoing research projects include programs to develop adjuvants for use with H5N1 pandemic influenza antigens as well as West Nile Virus vaccines.
At Emory, Compans has led research on ways to improve influenza vaccination, such as vaccines based on non-infectious virus - like particles and microneedle patches for delivery (now being tested clinically).
Last year, his research team created a high - yield influenza A vaccine virus candidate for cell culture production.
A vial of the NIAID Zika Virus Investigational DNA Vaccine, taken at the NIAID Vaccine Research Center's Pilot Plant in Frederick, Maryland.
In one eye - opening review of recent research, Charles Drake, M.D., Ph.D., of Johns Hopkins, who is also a member of CRI's clinical trials network, discussed several cancer vaccines that are making progress, including coxsackievirus A21, an oncolytic virus vaccine being studied in late stage melanoma, and NewLink's algenpantucel - L in pancreatic cancer (HyperAcute ® pancreas).
A research article published in the journal Science has reported the efficacy of three different vaccine platforms against the Zika virus in rhesus macaque monkeys.